FOI release

Freedom of Information responses from the MHRA - week commencing 28 February 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 28 February 2022

• From: Medicines and Healthcare products Regulatory Agency
• Published: 31 May 2022

Documents

Freedom of Information request on the death statistics following the COVID-19 vaccines (FOI 22/444)

HTML

Freedom of Information request on the adverse reactions reported relating to COVID-19 vaccinations (FOI 22/479)

HTML

Freedom of Information request on the adverse reactions reported via the yellow card scheme (FOI 22/497)

HTML

Freedom of Information request on the MHRA employment process (FOI 22/501)

HTML

Freedom of Information request on the weekly summary of yellow card reports and the COVID-19 vaccines (FOI 22/419)

HTML

Freedom of Information request on the adverse reactions reported from the Channel Islands, Jersey and Guernsey (FOI 22/446)

HTML

Freedom of Information request on the complaints of dehydration to the MHRA and Hollister (FOI 22/457)

HTML

Freedom of Information request on the yellow card reports for Imiquimod [of] skin discolouration, skin depigmentation, skin hypopigmentation and vitiligo (FOI 22/489)

HTML

Freedom of Information request on the COVID-19 vaccinations and Gene Therapy (FOI 22/500)

HTML

Freedom of Information request on the adverse reactions reported relating to COVID-19 vaccinations (FOI 22/505)

HTML

Freedom of Information request on the autologous dendritic cell vaccine production (FOI 22/506)

HTML

Freedom of Information request on the adverse reactions reported regarding the COVID-19 vaccinations (FOI 22/448)

HTML

Freedom of Information request on the approval status for Paxlovid and Molnupiravir (FOI 22/516)

HTML

Details

The Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 28 February 2022

Published 31 May 2022